Understanding current and emerging therapies for HNC

STATEMENT OF NEED/PROGRAM OVERVIEW Cancers that develop in and around the oral mucosa are collectively referred to as head and neck cancers (HNCs). Although the major risk factors (tobacco use and excessive alcohol use) and most prevalent population (persons older than 60 years) are well-known, a new patient demographic is emerging. A recently identified association between HNCs, particularly oropharyngeal cancer, and human papillomavirus (HPV) infection is reflected in increased incidence of oropharyngeal cancer in younger patients with no other risk factors. In addition, HPV status has an impact on response to treatment. This activity can help oncology nurses refresh their knowledge of the risks and treatments for HNCs, and keep pace with emerging trends in patient populations and new treatment approaches.